The Court of Justice of the European Union is expected to validate the European Commission’s fine of nearly €94 million imposed on the Danish pharmaceutical group Lundbeck for a cartel aimed at delaying the marketing of generics of its anti-depressant drug citalopram, Advocate General Juliane Kokott said in her Opinion delivered on Thursday 4 June (Case C-66/20).
Lundbeck appealed to the Court against the judgment of the General Court of the EU of September 2016 (T-472/13) which had...